Post- End- Expiratory Pressure Affect the Alveolar Heterogeneity in Moderate and Sever ARDS Patients
1 other identifier
observational
40
1 country
1
Brief Summary
This study try to use EIT ( Electronic impedance tomography ) to evaluate the alveolar heterogeneity and use trans-pulmonary pressure and stain to evaluate the lung injury . The study use these methods to figure out how PEEP impact the alveolar heterogeneity and VILI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2018
CompletedFirst Submitted
Initial submission to the registry
November 29, 2018
CompletedFirst Posted
Study publicly available on registry
December 4, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2023
CompletedJuly 19, 2022
July 1, 2022
5.3 years
November 29, 2018
July 17, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (11)
alveolar hyper-distention; alveolar collapse;alveolar opening and closing;
The study use Pulmo Vista 500 device (Drager co.),is intended to perform thoracic bioimpedance measurements by applying the technique of electrical impedance tomography (EIT)to evaluate alveolar hyper-distention(%of the lung volume); alveolar collapse(% of the lung volume);alveolar opening and closing(% of the lung volume).
September,1,2018-December 30, 2020
Trans-pulmonary pressure
The researchers place tube in the esophagus and connect it to transmitter to measure esophageal pressure (mmHg)and calculate trans-pulmonary pressure(mmHg) to evaluate stress
September,1,2018-December 30, 2020
EELV
The research use nitrogen wash out to measure EELV(end-expiratory lung volume, ml) to calculate dynamic strain and evaluate the strain
September,1,2018-December 30, 2020
peak pressure
The researchers use ventilator to measure peak pressure(cmH2O) in patients with mechanical ventilation and without spontaneous breathing..
September,1,2018-December 30, 2020
plateau pressure
The researchers use ventilator to do inspiration pause to measure plateau pressure(cmH2O) in patients with mechanical ventilation and without spontaneous breathing.
September,1,2018-December 30, 2020
tidal volume
The researchers use ventilator to measure tidal volume(ml) in patients with mechanical ventilation and without spontaneous breathing..
September,1,2018-December 30, 2020
respiratory rate
The researchers record the set respiratory rate(bpm) in patients with mechanical ventilation.
September,1,2018-December 30, 2020
flow
The researchers record the set Flow (L/min) in patients with mechanical ventilation.
September,1,2018-December 30, 2020
FiO2
The researchers record the set FiO2 ( fraction of inspiratory oxygen, %) in patients with mechanical ventilation.
September,1,2018-December 30, 2020
PaO2
The researchers use blood gas analysis to measure PaO2( arterial oxygen pressure,mmHg)
September,1,2018-December 30, 2020
PaCO2
The researchers use blood gas analysis to measure PaCO2( arterial carbon dioxide pressure,mmHg) .
September,1,2018-December 30, 2020
Secondary Outcomes (4)
SBP
September,1,2018-December 30, 2020
DBP
September,1,2018-December 30, 2020
CVP
September,1,2018-December 30, 2020
vasopressor
September,1,2018-December 30, 2020
Interventions
Titrate the PEEP from 24 cmH2O to 6 cmH2O, 2 cmH2O/step and record EIT, trans-pulmonary pressure, hemodynamic parameter and Blood-gas analysis.
Eligibility Criteria
Moderate or sever ARDS in 2012 \<Berlin definition\>;
You may qualify if:
- Age≥18 or\<80;
- Moderate or sever ARDS in 2012 \<Berlin definition\>;
- Applied mechanical ventilation;
- Consent signed.
You may not qualify if:
- Asthma or COPD;
- Cardiogenic edema;
- Sever neutropenia(\<500/mm3);
- Hemodynamic astatic: DOPA or Dobutamine \>15 µg/kg/ min; NE \> 15ug /min;
- GCS coma score ≤12;
- Thoracic injury or surgery patients contradict EIT ;
- Refuse to join in trail;
- Included in other clinical trail。
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nanjing Zhong-Da Hospital
Nanjing, Jiangsu, 210009, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
haibo qiu, PhD
Nanjing Zhong-Da Hospital, Southeast University School of Medicine,China
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
November 29, 2018
First Posted
December 4, 2018
Study Start
September 1, 2018
Primary Completion
December 30, 2023
Study Completion
December 30, 2023
Last Updated
July 19, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share